133 related articles for article (PubMed ID: 10622207)
1. The significance of NSE and CEA as a differentiation marker for the cellular heterogeneity of small cell lung cancer.
Kobayashi S; Okada S; Hasumi T; Sato N; Fujimura S
Tohoku J Exp Med; 1999 Sep; 189(1):37-49. PubMed ID: 10622207
[TBL] [Abstract][Full Text] [Related]
2. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Bepler G; Jaques G; Koehler A; Gropp C; Havemann K
J Cancer Res Clin Oncol; 1987; 113(3):253-9. PubMed ID: 2438285
[TBL] [Abstract][Full Text] [Related]
3. [A clinical evaluation of the versatility of various tumor markers in diagnosing the primary carcinoma of the lung].
Shimabukuro Z
Nihon Ika Daigaku Zasshi; 1989 Jun; 56(3):281-93. PubMed ID: 2546967
[TBL] [Abstract][Full Text] [Related]
4. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer.
Jaques G; Bepler G; Holle R; Wolf M; Hannich T; Gropp C; Havemann K
Cancer; 1988 Jul; 62(1):125-34. PubMed ID: 2838147
[TBL] [Abstract][Full Text] [Related]
6. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
Fizazi K; Cojean I; Pignon JP; Rixe O; Gatineau M; Hadef S; Arriagada R; Baldeyrou P; Comoy E; Le Chevalier T
Cancer; 1998 Mar; 82(6):1049-55. PubMed ID: 9506348
[TBL] [Abstract][Full Text] [Related]
7. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
Jørgensen LG; Hansen HH; Cooper EH
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.
Niho S; Nishiwaki Y; Goto K; Ohmatsu H; Matsumoto T; Hojo F; Ohe Y; Kakinuma R; Kodama T
Lung Cancer; 2000 Mar; 27(3):159-67. PubMed ID: 10699689
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serum tumor markers in patients with lung cancer.
Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
[TBL] [Abstract][Full Text] [Related]
10. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C
An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical detection of carcinoembryonic antigen and P-glycoprotein in small cell lung cancer at diagnosis and relapse, with special reference to the tissue expression of CEA and response to chemotherapy].
Ohnoshi T; Ueoka H; Segawa Y; Kiura K; Tabata M; Shibayama T; Maeda T; Miyatake K; Takigawa N; Kimura I
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Feb; 30(2):262-9. PubMed ID: 1351108
[TBL] [Abstract][Full Text] [Related]
13. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).
Shibayama T; Ueoka H; Nishii K; Kiura K; Tabata M; Miyatake K; Kitajima T; Harada M
Lung Cancer; 2001 Apr; 32(1):61-9. PubMed ID: 11282430
[TBL] [Abstract][Full Text] [Related]
14. Neuron-specific enolase (NSE) as a tumour marker and comparative evaluation with carcinoembryonic antigen (CEA) in small-cell lung cancer.
Adewole IF; Newlands ES
Med Oncol Tumor Pharmacother; 1987; 4(1):11-5. PubMed ID: 3037205
[TBL] [Abstract][Full Text] [Related]
15. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
Nutini S; Cappelli G; Benucci A; Catalani C; Nozzoli F
Int J Biol Markers; 1990; 5(4):198-202. PubMed ID: 1965544
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer.
Jaques G; Auerbach B; Pritsch M; Wolf M; Madry N; Havemann K
Cancer; 1993 Jul; 72(2):418-25. PubMed ID: 8391379
[TBL] [Abstract][Full Text] [Related]
17. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
[TBL] [Abstract][Full Text] [Related]
18. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
[TBL] [Abstract][Full Text] [Related]
19. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
Jørgensen LG; Osterlind K; Genollá J; Gomm SA; Hernández JR; Johnson PW; Løber J; Splinter TA; Szturmowicz M
Br J Cancer; 1996 Aug; 74(3):463-7. PubMed ID: 8695366
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
Spinazzi A; Soresi E; Boffi R; Nonis A; Noseda A; Cobelli S; Scanni A
Cancer Detect Prev; 1994; 18(3):209-20. PubMed ID: 8076383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
